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A recent study appeared in Nature Genetics in the May
issue (Robinson et al. 2016), revealed the casual relationship
between genetic variations and behavioural traits in human,
including those with the autism spectrum disorders (ASD).
The study demonstrated that the genetic variations associ-
ated with ASD—de novo as well as inherited mutations,
could possibly influence a wide spectrum of behavioural
trait, including those that are seen in the normal population,
and that ASD phenotype possibly represent one end of the
spectrum—the more severe form. This commentary is essen-
tially to discuss the significance of this study and its potential
outcome.
Recent advances in the genomic analyses have led to the
discovery of hundreds of causative genes for the monogenic
disorders (Antonarakis and Beckmann 2006). These studies
have also led the development of sensitive and reliable
diagnostic tools, better understanding the pathophysiological
process and disease management (Antonarakis and Beck-
mann 2006). As against this, the common complex disorders
are thought to be resulting from the involvement of mul-
tiple genes with additive effects and in combination with
environmental factors (Badano and Katsanis 2002). There-
fore, the progress in finding genes for complex disorders
has been rather slower and challenging, since the traditional
family-based mapping approaches could not be applied here.
The HapMap project and genomewide association study
(GWAS) have made major impact on discovering genetic risk
factors for a number of complex disorders, although the spe-
cific role for these risk factors in the disease process is far
from clear (Manolio and Collins 2009). Nonetheless, the risk
alleles in common disorders are often thought to increase the
susceptibility of developing the disease rather than being the
cause. Therefore, the distribution of such risk alleles differ
only marginally in the normal population as compared with
the affected (Manolio and Collins 2009). The frequency of
‘disease causing’ alleles of monogenic disorders on the other
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hand are rarer in normal population and hence are known as
‘disease-causing alleles’.
The neuropsychiatric disorders represent a heterogeneous
group with varied expressions and symptoms, and some of
them are thought to be developmental anomalies (Homberg
et al. 2016). Among these, the ASD represent a condition
where the affected child exhibits deficit in social interaction
and communication (Boyd et al. 2013; de laTorre-Ubieta et al.
2016). Such children also tend to show repetitive behaviours
(Boyd et al. 2013). The severity varies from being very mild
(hard to detect) to very severe, disabling conditions such
as lack of communication and often parents are the first to
notice the unusual behaviour of their children. The diagnosis
of ASD can be difficult and time-consuming (Boyd et al.
2013; Samadi et al. 2016). Intriguingly, some children with
ASD could show cognitive abilities higher than average age-
matched normal population (Charman et al. 2011). For exam-
ple, individual with ASD could have a higher IQ, and might
excel in one or the other stream of studies or skill sets. With
the overall incidence of around 1%, the ASD appears to be
about four times more common among boys than in girls
(Matelski and Van de Water 2016). Thus, sex of the individ-
ual appears to be one of the risk factors. Siblings with ASD,
children born to older parents, and environmental factors are
a few of the other risk factors (Matelski and Van de Water
2016). Twin studies have shown a major role of genetics in
ASD aetiology; a monozygotic twins show a concordance
rate between 60 and 90% for ASD, while it is about 5% for a
dizygotic twins (Bailey et al. 1995). Considering the skewed
male ratio, i.e. males are more affected with ASD, a poten-
tial role of X chromosome in ASD has been debated and
explored (Marco and Skuse 2006). Indeed, several studies
have suggested possible roles of two X-linked genes, FMRP
and MECP2, in the aetiology of ASD. Defects in the FMRP
gene are known to cause one of the common forms of mental
retardation—the fragile X syndrome (FXS), mostly affect-
ing the males as in the case of ASD (Lozano et al. 2014).
Although, the FXS patients share many of autistic features,
the FMRP locus appears to be involved only in a minor
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fraction (∼2%) of ASD cases (Reddy 2005). De novo muta-
tions in theMECP2gene are known to cause Rett syndrome—
a neurodevelopmental disorder predominantly affecting girls.
Rett syndrome patients show autistic-like behaviour in early
stages and eventually develop symptoms that are unique to
Rett syndrome (Feldman et al. 2016). The MECP2 gene
mutations, however, are rarer in ASD cases (Lobo-Menendez
et al. 2003), thus excluding its role in ASD. Mutations in
two other X-linked genes, NLGN3 and NLGN4, have been
shown to associate with ASD but only in a few cases (Jamain
et al. 2003). Similarly, anomalies in X chromosome, both
structural and numerical, have also been implicated in ASD
and again only in a smaller number of ASD cases (Evers
et al. 2015), suggesting a major role for autosomal genes in
the ASD aetiology. Indeed, a large number of studies have
tested this possibility and have used either the GWAS or
whole-exome sequencing approach to identify ASD associ-
ated genetic signatures. The outcome of such studies can be
grouped into two distinct classes: (i) rare inherited or de novo
mutations in a large number of genes occurring more pre-
dominantly in ASD cases (Iossifov et al. 2014; Krumm et al.
2015 ), and (ii) the common gene variants which are also
present but at a lower frequency in the normal population
contributing to the risk of ASD (Cross-Disorder Group of
the Psychiatric Genomics Consortium 2013; Gaugler et al.
2014). Given the fact that the ‘risk alleles’ are also found in
the normal population, one could argue that the ASD being a
quantitative phenotype, a few of the ASD ‘symptoms’ could
also be seen in so-called normal population. The ASD diag-
nosis being subjective and often based on the observations
and the feedback response, individuals who show marginal
‘phenotype’ yet fall below the threshold of being called as
ASD, can be considered as ‘normal’. Indeed, studies have
shown the increased incidence of a few of the autistic traits
in the biological relatives of ASD cases who are otherwise
not diagnosed as ASD. This raises an intriguing question
on the genetic similarities between the individuals that show
ASD and those that show ASD-like traits but considered as
normal in the population. The paper by Robinson and col-
leagues (2016) tested this possibility and demonstrated that
the genetic influence for ASDs could result in a continuum
of ‘behavioural and developmental traits’. The authors of
this article have used different datasets to build their model
and to validate. These include the genomic data (common
nucleotide variants and de novo mutations—derived from
GWAS and whole-exome sequencing data) and their corre-
lation with the ASD phenotype as well as with the social
and communication difficulties (SCD), as defined by the
Social and Communication Disorders Checklist (Boyd et al.
2013), in individuals representing the general population.
These data were derived from large consortium studies, some
of them have already been in the public domains, thereby
involving a substantially large sample size (exceeding 10,000
for each group). A significant aspect of the study was to
compare the genomic profile between the ASD cases and the
individuals from the normal population who showed SCD
and replicating the studies with other cohort. The authors
have also compared the genetic signatures of individuals with
other neuropsychiatric disorders, such as schizophrenia, with
those that show ASD to see the overlap in the genetic risk
factors. The authors demonstrated that nearly one fourth of
the genetic risk factors associated with the ASD phenotype
are also associated with SCD and that this correlation is
independent of the race or the geographical location of the
population studied. The authors also demonstrated a similar
level of overlap for the genetic signatures in individuals
from the same cohort having neuropsychiatric disorders
such as schizophrenia and other manic disorders. To further
strengthen their observations, the authors have also looked at
the occurrence of the de novomutations in the cohorts they have
studied. Their data correlated a continuum of genetic burden
with the continuum in behavioral traits in the study subjects.
Thus, the ASD could represent the one end of the behavioural
spectrum. The siblings of ASD cases, who often share many
of the genetics signatures of ASD are at higher risk of devel-
oping SCD. This study thus provides a genetic basis to sug-
gest that social behaviour is indeed a continuous trait and
its distribution/expression in the population varies along a
continuum, just like the other textbook examples of the quan-
titative traits—the height, learning ability and skin colour.
This study and its approach are first of its kind, and there-
fore, is a seminal contribution in understanding the com-
plexity of a polygenic trait in humans. Similar approach can
now be extended to investigate other traits, such as neuropsy-
chiatric or neurodevelopmental disorders, and to understand
their genetic basis.
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